Paras Healthcare Limited
NSE: PARASHLTH | Information Technology
Market Fundamentals
Stock Intelligence & News
Q2 Results Today Live: Reliance, Jio Platforms, Sun Pharma, Dixon, BEL, IOC, BoB, GAIL, GE Vernova, Lodha, Max Health, Delhivery, Aether, NTPC Green to announce Q2 results, Coal India, Trent, IndiGo, Asian Paints, Ambuja Cements, Welspun Corp, Milky Mist, Suzlon, Godrej, PN Gadgil, Paras Defence, Blue Star shares in focus
Q2 Results Today, 30th October 2026 Live Updates: businessline brings to you latest Q2 announcements, earnings updates and more.
Read Full Analysis →Paras Defence and Space Technologies Ltd (543367)
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026
Read Full Analysis →Paras Defence and Space Technologies Limited
Paras Defence And Space Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Paras Defence posts 37% revenue jump in Q2 FY27, net profit rises 37% to ₹30.4 cr
Paras Defence stock closes at ₹1,329.70 on NSE, up 2.08% on the day, giving the company a market capitalisation of approximately ₹10,716 crore
Read Full Analysis →Paras Defence Q2 Results: Profit Jumps 47% As Optics Revenue Nearly Doubles
The optics and optronic systems segment drove growth, with revenue surging 94.2% to Rs 74.7 crore from Rs 38.4 crore a year earlier.
Read Full Analysis →Paras Healthcare shares: After IPO listing gains, check what's happening with stock - Buy, sell or hold?Experts weigh in
Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.
Read Full Analysis →Paras Healthcare shares to list today: Check GMP ahead of debut
The Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares aggregating to Rs 950 crore. The company fixed the price band at Rs 660–693 per share, with a lot size of 21 shares. At the upper end of the price band, retail investors applying for one lot were required to invest a minimum of Rs 14,553.
Read Full Analysis →Jio Platforms Vs Paras Healthcare: What Does GMP Indicate Ahead Of Listing?
The latest grey market data indicates stronger unofficial demand expectations for Jio Platforms compared with Paras Healthcare.
Read Full Analysis →Tonbo Imaging vs Paras Defence: Which is the better defence stock?
India's defence indigenization push is creating opportunities for specialized players. Which of these two companies is performing better?
Read Full Analysis →Listing of Equity Shares of Paras Healthcare Limited
Listing of Equity Shares of Paras Healthcare Limited
Read Full Analysis →Get instant alerts when PARASHLTH breaks news
Join investors who track Paras Healthcare Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for PARASHLTH?
PARASHLTH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Paras Healthcare Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding PARASHLTH to your custom watchlist.